Literature DB >> 18836581

Deficit schizophrenia: an update.

Brian Kirkpatrick1, Silvana Galderisi.   

Abstract

The criteria for deficit schizophrenia were designed to define a group of patients with enduring, primary (or idiopathic) negative symptoms. In 2001, a review of the literature suggested that deficit schizophrenia constitutes a disease separate from nondeficit forms of schizophrenia. Here we provide a review of new studies, not included in that paper, in which patients with deficit schizophrenia and those with nondeficit schizophrenia were compared on dimensions typically used to distinguish diseases: signs and symptoms, course of illness, pathophysiological correlates, risk and etiological factors, and treatment response. Replicated findings and new evidence of double dissociation supporting the separate disease hypothesis are highlighted. Weaknesses in research and treatment options for these patients are also emphasized.

Entities:  

Keywords:  Deficit schizophrenia; apathy; double dissociation; heterogeneity; negative symptoms

Year:  2008        PMID: 18836581      PMCID: PMC2559917          DOI: 10.1002/j.2051-5545.2008.tb00181.x

Source DB:  PubMed          Journal:  World Psychiatry        ISSN: 1723-8617            Impact factor:   49.548


  58 in total

1.  Neurological signs and the heterogeneity of schizophrenia.

Authors:  C Arango; B Kirkpatrick; R W Buchanan
Journal:  Am J Psychiatry       Date:  2000-04       Impact factor: 18.112

Review 2.  The structure of negative symptoms within schizophrenia: implications for assessment.

Authors:  Jack J Blanchard; Alex S Cohen
Journal:  Schizophr Bull       Date:  2005-10-27       Impact factor: 9.306

3.  Three dimensions of clinical symptoms in elderly patients with schizophrenia: prediction of six-year cognitive and functional status.

Authors:  Eran Chemerinski; Abraham Reichenberg; Brian Kirkpatrick; Christopher R Bowie; Philip D Harvey
Journal:  Schizophr Res       Date:  2006-04-19       Impact factor: 4.939

4.  D-serine added to clozapine for the treatment of schizophrenia.

Authors:  G E Tsai; P Yang; L C Chung; I C Tsai; C W Tsai; J T Coyle
Journal:  Am J Psychiatry       Date:  1999-11       Impact factor: 18.112

5.  P300 subcomponent abnormalities in schizophrenia: I. Physiological evidence for gender and subtype specific differences in regional pathology.

Authors:  B I Turetsky; E A Colbath; R E Gur
Journal:  Biol Psychiatry       Date:  1998-01-15       Impact factor: 13.382

6.  Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome.

Authors:  C A Tamminga; G K Thaker; R Buchanan; B Kirkpatrick; L D Alphs; T N Chase; W T Carpenter
Journal:  Arch Gen Psychiatry       Date:  1992-07

7.  Dihydropyrimidinase-related protein 2 (DRP-2) gene and association to deficit and nondeficit schizophrenia.

Authors:  L Elliot Hong; Ikwunga Wonodi; Matthew T Avila; Robert W Buchanan; Robert P McMahon; Braxton D Mitchell; O Colin Stine; William T Carpenter; Gunvant K Thaker
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2005-07-05       Impact factor: 3.568

8.  Catechol-O-methyltransferase Val158Met polymorphism in schizophrenia: associations with cognitive and motor impairment.

Authors:  Silvana Galderisi; Mario Maj; Brian Kirkpatrick; Paola Piccardi; Armida Mucci; Giordano Invernizzi; Alessandro Rossi; Stefano Pini; Antonio Vita; Paolo Cassano; Paolo Stratta; Giovanni Severino; Maria Del Zompo
Journal:  Neuropsychobiology       Date:  2005-07-19       Impact factor: 2.328

9.  Components of the smooth pursuit function in deficit and nondeficit schizophrenia.

Authors:  L Elliot Hong; Matthew T Avila; Helene Adami; Amie Elliot; Gunvant K Thaker
Journal:  Schizophr Res       Date:  2003-09-01       Impact factor: 4.939

10.  Double dissociation of N1 and P3 abnormalities in deficit and nondeficit schizophrenia.

Authors:  Armida Mucci; Silvana Galderisi; Brian Kirkpatrick; Paola Bucci; Umberto Volpe; Eleonora Merlotti; Fausto Centanaro; Francesco Catapano; Mario Maj
Journal:  Schizophr Res       Date:  2007-03-23       Impact factor: 4.939

View more
  59 in total

1.  Inflammatory markers in antipsychotic-naïve patients with nonaffective psychosis and deficit vs. nondeficit features.

Authors:  Clemente Garcia-Rizo; Emilio Fernandez-Egea; Cristina Oliveira; Azucena Justicia; Miguel Bernardo; Brian Kirkpatrick
Journal:  Psychiatry Res       Date:  2012-03-08       Impact factor: 3.222

2.  Gray matter volume alterations in first-episode drug-naïve patients with deficit and nondeficit schizophrenia.

Authors:  Wei Lei; Wei Deng; Mingli Li; Zongling He; Yuanyuan Han; Chaohua Huang; Xiaohong Ma; Qiang Wang; Wanjun Guo; Yinfei Li; Lijun Jiang; Qiyong Gong; Xun Hu; Nanyin Zhang; Tao Li
Journal:  Psychiatry Res       Date:  2015-09-11       Impact factor: 3.222

3.  An Early Developmental Marker of Deficit versus Nondeficit Schizophrenia.

Authors:  Brian Kirkpatrick; Özlem Gürbüz Oflezer; Mehtap Delice Arslan; Gary Hack; Emilio Fernandez-Egea
Journal:  Schizophr Bull       Date:  2019-10-24       Impact factor: 9.306

Review 4.  What do we really know about blunted vocal affect and alogia? A meta-analysis of objective assessments.

Authors:  Alex S Cohen; Kyle R Mitchell; Brita Elvevåg
Journal:  Schizophr Res       Date:  2014-09-26       Impact factor: 4.939

5.  Anxiety does not contribute to social withdrawal in the subchronic phencyclidine rat model of schizophrenia.

Authors:  Alexandre Seillier; Andrea Giuffrida
Journal:  Behav Pharmacol       Date:  2017-10       Impact factor: 2.293

Review 6.  Psychometric evaluation of the negative syndrome of schizophrenia.

Authors:  Maria Paz Garcia-Portilla; Leticia Garcia-Alvarez; Pilar A Saiz; Susana Al-Halabi; Maria Teresa Bobes-Bascaran; Maria Teresa Bascaran; José Muñiz; Julio Bobes
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-03-24       Impact factor: 5.270

7.  Seasonality of births in horizontal strabismus: comparison with birth seasonality in schizophrenia and other disease conditions.

Authors:  A B Agarwal; K Cassinelli; L A Johnson; K Matsuda; B Kirkpatrick; W Yang; C S von Bartheld
Journal:  J Dev Orig Health Dis       Date:  2019-03-22       Impact factor: 2.401

8.  The current conceptualization of negative symptoms in schizophrenia.

Authors:  Stephen R Marder; Silvana Galderisi
Journal:  World Psychiatry       Date:  2017-02       Impact factor: 49.548

9.  Confirmatory factor analysis of the quality of life scale and new proposed factor structure for the quality of life scale-revised.

Authors:  Kim T Mueser; Min Kim; Jean Addington; Susan R McGurk; Sarah I Pratt; Donald E Addington
Journal:  Schizophr Res       Date:  2016-10-15       Impact factor: 4.939

10.  The risk of diabetes in deficit schizophrenia.

Authors:  William R Keller; Carol Vidal; Eric S Park; Gregory P Strauss; Bernard A Fischer
Journal:  Clin Schizophr Relat Psychoses       Date:  2014-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.